Open Access Article
Tiexin Zhang
*a,
Pengfang Wanga,
Zirui Gaoa,
Yang Ana,
Cheng He
a and
Chunying Duan*ab
aState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian 116024, China. E-mail: zhangtiexin@dlut.edu.cn; cyduan@dlut.edu.cn; Fax: +86-411-84986476; Tel: +86-411-84986476
bCollaborative Innovation Center of Chemical Science and Engineering, Tianjin 300071, China
First published on 24th September 2018
The photocatalytic atom-transfer radical addition (ATRA) of perfluoroalkyl iodides onto olefins is of potential biointerest; the relatively negative reductive potential of perfluoroalkyl iodide makes it difficult to generate the perfluoroalkyl radical by the photoinduced single-electron transfer from the excited state of the photocatalyst. In the presence of the easily available well-known pyrene-based metal–organic framework (MOF) NU-1000, the ATRA was achieved for iodoperfluooralkylation of olefins in a heterogeneous mode upon 405 nm visible-light irradiation with LEDs. The investigation supports a mechanism whereby the pyrene-based chromophores within NU-1000 photochemically generate the reactive radical species by sensitisation of the perfluoroalkyl iodides through an energy-transfer (EnT) pathway. Besides the activation of singlet oxygen for oxidative application, it is the first time to directly utilise the photoinduced EnT process of MOFs in organic transformations. Compared with the photocatalysis using homogeneous free ligand or other pyrene-based MOFs, the spatial isolation of chromophores in NU-1000 is believed to hamper the destructive excited-state energy loss from self-quenching or interligand interactions, ensuring the efficiency of reaction. When employing conjugated arylalkenes as substrates, the photocatalytic ATRA reaction, the HI elimination of the ATRA product, and the EnT-mediated (E)/(Z)-isomerisation could be merged together in one-pot to afford highly (Z)-selective perfluoroalkyl styrenes, which might be attractive in the pharmaceutical field.
![]() | ||
| Scheme 1 (a) Mechanistic diagram of formation of perfluoroalkyl (Rf) radicals via different photocatalytic routes. (PC = photocatalyst, LA = Lewis acid, EnT = energy transfer) (b) comparison of oxidative potentials9–12 and bond dissociation energies (BDEs)14 of diethyl 2-bromomalonate and RfI, favouring different strategies for generation of radicals. (c) Schematic illustration of EnT induced homolytic cleavage of RfI to generate perfluoroalkyl radical for ATRA by using pyrene-based MOF NU-1000 under visible-light irradiation of 405 nm LEDs. | ||
Due to the good visible-light harvesting22–26 and powerful triplet photosensitising ability,27–29 the organic dye pyrene-based chromophores mediated EnT processes have been involved in the singlet oxygen generation,30 and other hot topics like fluorescence resonance energy transfer (FRET)31 or up-conversions,32,33 and those processes were widely applied in the bioinspired applications such as protein labelling,34 and biosensing.35 The aggregation state of pyrene-derivatives imposed great impact on light-harvesting, EnT, or other aspects of their photochemical/physical performances.36–40 Thus, this aggregation state-induced modulation was envisioned to be more controllable when assembling pyrene-based chromophores in a highly uniform manner within crystalline materials like metal–organic frameworks (MOFs).41 As a well-known representative of pyrene-based MOF,42–44 NU-1000 is constructed from 1,3,6,8-tetrakis(p-benzoic acid)pyrene (H4TBAPy) and zirconium ions,45 The open channels of NU-1000 facilitate the diffusion of substrates/reagents for the efficient conversion, the spatial isolation of TBAPy moieties within framework avoids the self-quenching or photobleaching of chromophores, and the strong coordination between zirconium ions and carboxylate groups of ligands endows NU-1000 with excellent durability for its recycle after use. Note that the photoreductive potential of excited-state NU-1000+/NU-1000* couple (ca. −1.12 eV, Fig. 1) is not negative enough to drive the PET-induced reduction of RfI to form the Rf radical (Scheme 1b), thus the EnT process mediated by NU-1000 might be the alternative way to homolytic cleavage C–I of RfI for generating Rf radicals to initiate ATRA reactions (Scheme 1c). In the pioneering works of Farha,46–48 Kim, and Lee,49 the EnT processes of NU-1000 and other pyrene-based MOFs have been successfully utilised in the activation of singlet oxygen for oxidative applications. In comparison, the direct use of photoinduced EnT of MOF for organic transformations is still in the infancy stage, and the EnT-induced formation of carbon-centred radicals by using MOFs have never been reported before. Herein, we report the EnT-mediated ATRA reaction of RfI onto olefins for the first time by using pyrene-based MOF NU-1000 under visible-light irradiation.
| Entry | Photocatalyst (mol%) | Light source | C8F17I/lutidine (x/y equiv.) | Yieldb (%) |
|---|---|---|---|---|
| a Reaction conditions: 1a (0.25 mmol, 1.0 equiv.), RfI 2a and additive base 2,6-lutidine (specified amounts), photocatalyst (specified amount calculated based on pyrene moiety), degassed acetonitrile (1.0 mL), room temperature (r.t.) and N2 atmosphere, 12 h.b Isolated yields.c NMR yield is shown in parenthesis.d Calculated based upon the amount of 2a. | ||||
| 1 | NU-1000 (2.5) | Xe light | 2/2 | 37 |
| 2 | NU-1000 (2.5) | Xe light (>400 nm) | 2/2 | 59 |
| 3 | NU-1000 (2.5) | LED (455 nm) | 2/2 | 63 |
| 4 | NU-1000 (2.5) | LED (405 nm) | 2/2 | 93(98)c |
| 5 | NU-1000 (2.5) | LED (405 nm) | 1.2/1.2 | 66 |
| 6 | NU-1000 (2.5) | LED (405 nm) | 0.5/0.5 | 57d |
| 7 | NU-1000 (5.0) | LED (405 nm) | 2/2 | 94 |
| 8 | NU-1000 (1.25) | LED (405 nm) | 2/2 | 61 |
| 9 | NU-1000 (2.5) | Dark | 2/2 | 0 |
| 10 | NU-1000 (2.5) | LED (405 nm) (in air) | 2/2 | Trace |
| 11 | None | LED (405 nm) | 2/2 | 0 |
| 12 | NU-1000 (2.5) | LED (405 nm) | 2/0 | 0 |
| 13 | Pyrene (2.5) | LED (405 nm) | 2/2 | Trace |
| 14 | H4TBAPy (2.5) | LED (405 nm) | 2/2 | 16 |
| 15 | ZrCl4 (7.5) + H4TBAPy (2.5) | LED (405 nm) | 2/2 | 21 |
| 16 | NU-901 (2.5) | LED (405 nm) | 2/2 | 81 |
The photocatalyst plays a vital role in this ATRA reaction, switching MOF to the homogeneous pyrene molecule gave ignorable amount of conversion (entry 13). The integrity of MOF catalyst is also important, only using the free ligand 1,3,6,8-tetrakis(p-benzoic acid)pyrene (H4TBAPy) or the simply mixed free ligand and zirconium salt as photocatalyst resulted in sharp falls in conversions (entries 14 and 15). Next, NU-901,50,51 another MOF constructed from H4TBAPy and zirconium salt but featured with different topology and stronger interchromophoric interaction than NU-1000,52 was also amenable to driving this reaction but in lower efficiency (entry 16), reflecting the advantage for NU-1000 in reducing the undesirable energy loss of excited state by its weaker inter-ligand interactions.
Then, the heterogeneity of this photocatalytic system was explored, as shown in Fig. 2. Removal of MOF particles by hot-filtration after 0.5 h shut down the reaction immediately (Fig. 2a), and zirconium ions could not be detected from the supernatant of reaction mixture by Inductively coupled plasma mass spectrometry (ICP-MS), excluding the possible decomposition of NU-1000. After the reaction, the MOF solids could be easily recovered by simple filtration, and then reused for at least 5 cycles without remarkable deterioration in activity (Fig. 2b). There were not significant changes of powder X-ray diffraction (XRD) patterns (Fig. 2c) and infrared (IR) spectrum of photocatalyst NU-1000 (Fig. 2d) before and after the reactions, which disclosed the maintenance of the crystallinity and composition of MOF NU-1000, furtherly demonstrating the important role of structural rigidity for the durable catalytic performance.
With optimized conditions in hand, we explored the substrate scope of the ATRA of RfI 2 onto olefins 3. The relative results were summarized in Table 2. In the presence of 2.5 mol% of NU-1000, the aliphatic terminal alkenes 1a to 1c bearing hydrophilic hydroxyl or hydrophobic phenyl/phenoxy substituents on the other ends of olefins were smoothly transformed into the corresponding difunctionalized products in moderate to high yields (3a to 3g). The perfluoroalkyl radical precursor 2 bearing longer perfluoroalkyl chains gave higher reaction efficiency than the ones with shorter perfluoroalkyl chains (entries 1 to 4 and entries 5 and 6). Judging from the trend of conversions, the reactivities of RfI 2 might be negatively correlated with the BDEs of their C–I bonds.10,14,53 It should be noted that the 2,2,2-trifluoroethyl iodide 2d, which was difficult to be reduced owing to its considerably high reductive potential (ca. −1.80 V vs. SCE),53 could also engage in this reaction to give a 67% isolated yield of desired product 3d.
The naturally occuring compound bearing terminal olefin like (−)-β-pinene 1h, was also examined in this photocatalytic system (Scheme 2), and the four-membered spiroring of 1h was found to undergo a ring-opening process at the bridgehead carbon position near the alkene moiety to release the ring strain of the intermediate with a neighboring carbon centered radical, which was an evidence for the addition of perfluoroalkyl radical towards olefin moiety. However, the desired product 3h was subject to a base-assisted elimination of HI after the ATRA step, yielding a mixture of 4h and 4h′ with a ratio of ca. 50
:
50.
![]() | ||
| Scheme 2 Evaluating the scope of the photocatalytic ATRA using aliphatic olefin bearing naturally occurring compound. Isolated yields. | ||
To investigate the mechanism of this photocatalytic ATRA reaction, 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) was employed as the radical scavenger. When 1.2 equiv. of TEMPO was added, the photocatalytic ATRA reaction was totally suppressed (Scheme 3a). Then, a radical clock experiment was conducted by using an intramolecular diallyl containing substrate 1i, furnishing 5-exo-trig radical cyclization in 86% yield (Scheme 3b). Those results together with the detection of I2 (Scheme 3c–e) well demonstrated the generation of perfluoroalkyl and iodine radical, implying the homolytic cleavage of C–I bonds of RfI.
It is known that the outer-sphere single-electron transfer reduction of alkyl halides depends on their reductive potentials. In comparison, the inner-sphere electron transfer or EnT process are sensitive to the BDEs of carbon–halogen bonds of the alkyl halides and the nature of the halogen.54–56 The conversion plots of photocatalytic ATRA of various alkyl halides 2 onto 1a vs. the BDEs of carbon–halogen bonds,14 and vs. the oxidative potentials of the alkyl halides,57–59 were shown in Scheme 4. It was evident from the two sets of plots that a better correlation of the reaction conversions was obtained with BDEs (Scheme 4a) than with reductive potentials (Scheme 4b), indicative of an inner-sphere electron transfer or EnT pathway. It was shown that the alkyl halides with lower BDEs roughly underwent more efficient ATRA reactions in this photocatalytic system, and nearly no conversion was observed in the case of using carbon tetrachloride (2l) which was featured with a moderate oxidative potential (−0.64 V vs. SCE) but a high BDE (298 kJ mol−1). Although the presence of electron transfer pathways were still difficult to be excluded, it was theoretically less possible for a pyrene-based Zr-MOF to undergo an inner-sphere electron transfer process without the assistance of transition metal ions.60
The very recent computational works of Deria and coworkers revealed the correlation between the topological structures of pyrene-based MOFs and their photoinduced excited-state property,52,61 and the energy levels of singlet excited state S1 of NU-1000 and the isomeric NU-901 were caculated to be ca. 294 kJ mol−1 (ca. 3.05 eV) and ca. 256 kJ mol−1 (ca. 2.65 eV), repectively, endowing NU-1000 with theoretical possibility of driving the more efficient EnT mediated homolytic bond cleavage of RfI with medium BDE values in comparison to alkyl halides with much higher BDEs (Schemes 1b and 4a). Noticeably, the luminescence intensity of NU-1000 was significantly quenched upon the addition of C4F9I (2c) (Fig. 3a), and the luminescence lifetime of NU-1000 also decreased from 7.59 ns to 6.92 ns after addition of 2c (Fig. 3b), both phenomena evidenced the photoinduced singlet–singlet EnT process from excited-state NU-1000 to the perfluoroalkyl iodide molecules.62–65
As previously mentioned, the ATRA reaction hugely diminished in the presence of O2 (ΔET1→S1 = ca. 95 kJ mol−1) as an effective triplet energy quencher of excited state (Table 1, entry 10).66 Then, the ATRA reaction of 2c and 1a was performed in the presence of triplet quenchers with different triplet state energies, and the triplet quencher 2,5-dimethyl hexa-2,4-diene, which triplet-state energy (ET = ca. 243 kJ mol−1) was much lower than that of another triplet quencher pyridazine (ET = ca. 297 kJ mol−1),19 was found to depress the conversion more effectively than pyridazine (Table 3, entries 1 and 2),67 the results of these triplet quenching experiments together with the reported works on photocatalytic singlet oxygen generation by using pyrene-based MOFs46–49 further implied the possible existence of triplet excited state of NU-1000 generated from singlet-to-triplet intersystem crossing during the photocatalysis.68 According to the computational results of Deria and coworkers, the topology-determined inter-ligand interactions within MOFs facilitated the transitions among different excited states (such as transitions among optically relevant S1, S2, and Sn states), lengthened their lifetime, and expedited their spatial shifts across the ligands in comparison to the free ligand H4TBAPy,61 providing more possible routes to the formation of triplet excited states of MOFs for EnT processes during photocatalysis. Moreover, compared with stronger inter-ligand interactions within MOF NU-901, the weaker inter-ligand interactions within NU-1000 were helpful to retain the energy level of excited state by avoiding the excited-state energy losses owing to stronger inter-ligand interactions,61 benefiting the more effective EnT process for homolytic bond break of RfI (Table 1, entries 4 and 16).
The application of this photocatalytic strategy was further expended to ATRA of aliphatic and aromatic terminal alkynes, furnishing iodoperfluoroalkylation of carbon–carbon triple bonds in good yields (Scheme 5). Interestingly, although the (E)-geometries of ATRA products were still more favoured, the corresponding ratios of (Z)-/(E)-isomers were higher than most of the reported results in literatures.20,69–71 These phenomena gave a strong hint of triplet EnT induced enrichment of (Z)-alkenes, and the (E)- to (Z)-conversion was confirmed by exposing (E)-isomer of 6b to the reaction condition (Scheme 5). The heavy-atom effect of iodo group of product 6b was believed to facilitate the conversion from (E)- to (Z)-geometry.74–78 Simultaneously, the EnT-induced intersystem crossing behaviour of conjugated arylalkene also imposed an competitive driving force to pull the perfluoroalkyl group to the ‘(Z)’-side of aryl moiety (caution: here, the (Z)-geometry relative to aryl is equivalent to the (E)-geometry relative to iodine atom). The ratio of (Z)-/(E)-isomers should represent the balance status of ‘tug-of-war’ between iodo and aryl group, and it was interesting to examine the (Z)-/(E)-ratio if iodine atom of 6b was absent, since it might provide a pathway for the facile preparation of (Z)-enriched perfluoroalkyl styrenes (caution: the (Z)-geometry here refers to the case of aryl moiety) which was of potential interest in pharmaceutical field and generally needed multi-step synthesis.79,80
![]() | ||
| Scheme 5 Evaluating the scope of the photocatalytic ATRA using aliphatic and aromatic terminal alkynes. Isolated yields. | ||
By merging photocatalytic ATRA of RfI onto styrene and subsequent elimination of HI together in one pot, we successfully developed a strategy for the highly stereoselective preparation of (Z)-perfluoroalkyl styrene derivatives 7 in moderate to good yields (Scheme 6). To the best of our knowledge, it was the first time to develop the direct transformation from styrene to (Z)-selective perfluoroalkyl styrene. The biointeresting fragment such as estrone derivative could be tolerated in this heterogeneous photocatalytic tandem reaction (7c), showing the potential value of this method in pharmaceutical field. The ATRA step was proven to be first stage in this one pot process, the ATRA product 3m was successfully isolated in a yield of 64% when ceasing the reaction at 4 h, and re-subjecting 3m into reaction condition steadily gave rise to the formation of desired 7a. The (E)-isomer of product could not be detected either from the reaction mixture of one pot conversion or that of stepwise process, implying that the (Z)-geometry product was rapidly formed once upon elimination of HI. In comparison, this reaction gave much lower efficiency and inferior stereoselectivity in the presence of free ligand H4TBAPy instead of using NU-1000 (Scheme 6 and 7c‡), showing the significance of structure of NU-1000 in conducting this tandem process and enriching the (Z)-isomers.
Based upon our experimental results and the previous experimental19,20 and computational52,61 works, a possible mechanism was outlined in Scheme 7. The singlet–singlet EnT from the excited-state NU-1000 to RfI triggered the homolytic cleavage of carbon–iodine bond of RfI to generate perfluoroalkyl and iodine radicals which were added towards the β- and α-positions of olefin, repectively, furnishing the ATRA reaction (Scheme 7, Pathway A). In the case of employing aromatic alkenes as substrates, the ATRA products easily underwent the base-assisted elimination of HI, then the obtained (E)/(Z)-isomeric mixtures were imposed with another EnT process from the triplet excited state of NU-1000,81 forging the (E)/(Z)-isomerisation to enrich the (Z)-isomer (Scheme 7, Pathway B).72,73
NMR spectra were measured on a Bruker Avance 500 WB or Bruker Avance 400 WB spectrometers, and the relative chemical shifts were recorded in parts per million (ppm, δ). Powder X-ray diffractograms (PXRD) experiments were performed with PANalytical Empyrean X-ray powder diffractometer (Cu Kα radiation, 40 kV, 40 mA). Elemental analysis with inductively coupled plasma-atomic emission spectroscopy (ICP-MS) was measured on a Shimadzu ICPE-9000. FT-IR spectra were recorded as KBr pellets on JASCO FT/IR-430. High-resolution mass spectrum (EI) were recorded on a Micromass GC-TOF mass spectrometer.
Solid state cyclic voltammograms were conducted by using a carbon-paste working electrode; a well-ground mixture of each bulk sample and carbon paste (graphite and mineral oil) was set in the channel of a glass tube and connected to a copper wire. A platinum-wire counter electrode and an Ag/AgCl reference electrode were utilised. Measurements were conducted by using a three-electrode system in an aqueous solution of KNO3 (0.1 M) at a scan rate of 200 mV s−1.
The solid and liquid fluorescent spectrum were measured on an Edinburgh FS920 instrument. The excitation and emission slits were both 3 nm wide, and the wavelengths of excitation and emission were chosen according to specific cases. The time resolved luminescence spectrum were measured in an Edinburgh FLS920 spectrometer.
The reactions catalyzed by other kinds of (or other specified amounts of) pyrene-based heterogeneous/homogeneous species were conducted by similar manners.
1.2 equiv. of radical scavenger TEMPO (Scheme 3a) or triplet quencher (2,5-dimethylhexa-2,4-diene/pyridazine, Table 3) was also added to the reaction mixture besides the other components in the case of corresponding quenching experiments.
In case of the hot filtration experiment, the photocatalyst solid particles were filtered off by a syringe filter at 0.5 h under positive pressure of N2, and the filtrate was transferred to another pre-dried Pyrex tube, stirred, and irradiated by visible light of 405 nm LEDs under N2 atmosphere. The timely-monitoring of conversion of 1a was performed in the same way, as shown above.
:
1 v/v) as the eluent system. 1H NMR (400 MHz, CDCl3) δ 4.39–4.29 (m, 1H), 3.69 (t, J = 6.0 Hz, 2H), 3.03–2.68 (m, 2H), 1.94–1.78 (m, 2H), 1.72–1.47 (m, 4H), 1.30 (br s, 1H). 13C NMR (126 MHz, CDCl3) δ 62.7, 41.9 (t, J = 20.9 Hz), 40.3 (d, J = 1.8 Hz), 31.8, 26.2, 20.6. 19F NMR (470 MHz, CDCl3) δ −80.77 (t, J = 9.8 Hz, 3F), −111.13 to −115.08 (m, 2F), −121.56 (virt. s, 2F), −121.91 (virt. s, 4F), −122.72 (virt. s, 2F), −123.57 (virt. s, 2F), −126.10 (virt. s, 2F).
:
1 v/v) as the eluent system. 1H NMR (500 MHz, CDCl3) δ 4.34 (ddd, J = 13.4, 8.8, 5.0 Hz, 1H), 3.69 (t, J = 6.0 Hz, 2H), 3.01–2.86 (m, 1H), 2.79 (ddt, J = 31.3, 15.7, 7.9 Hz, 1H), 1.92–1.78 (m, 2H), 1.68–1.47 (m, 4H), 1.31 (br s, 1H). 13C NMR (126 MHz, CDCl3) δ 62.7, 41.9 (t, J = 20.8 Hz), 40.3 (d, J = 1.8 Hz), 31.8, 26.2, 20.6. 19F NMR (470 MHz, CDCl3) δ −79.47 to −82.07 (m, 3F), −110.36 to −115.76 (m, 2F), −121.75 (virt. s, 2F), −122.72 to −123.00 (m, 2F), −123.59 (virt. s, 2F), −126.05 to −126.27 (m, 2F).
:
1 v/v) as the eluent system. 1H NMR (400 MHz, CDCl3) δ 4.39–4.27 (m, 1H), 3.69 (t, J = 5.6 Hz, 2H), 2.95–2.71 (m, 2H), 1.95–1.77 (m, 2H), 1.71–1.47 (m, 4H), 1.33 (br s, 1H). 13C NMR (126 MHz, CDCl3) δ 62.7, 41.8 (t, J = 20.8 Hz), 40.3 (d, J = 2.1 Hz), 31.8, 26.2, 20.6. 19F NMR (470 MHz, CDCl3) δ −80.98 to −81.05 (m, 3F), −111.42 to −115.38 (m, 2F), −124.53 (virt. s, 2F), −125.75 to −126.05 (m, 2F).
:
1 v/v) as the eluent system. 1H NMR (500 MHz, CDCl3) δ 4.07 (dq, J = 13.2, 4.4 Hz, 1H), 3.68 (t, J = 6.0 Hz, 2H), 2.48–2.34 (m, 1H), 2.28–2.14 (m, 1H), 2.12–1.98 (m, 2H), 1.98–1.89 (m, 1H), 1.75 (ddd, J = 14.2, 9.9, 5.3 Hz, 1H), 1.68–1.59 (m, 3H), 1.55–1.48 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 127.0 (d, J = 276.3 Hz), 62.8, 40.6, 35.7, 34.4 (q, J = 28.9 Hz), 33.0 (q, J = 2.9 Hz), 31.9, 26.0. 19F NMR (470 MHz, CDCl3) δ −65.89 (t, J = 10.6 Hz).
:
1 v/v) as the eluent system. 1H NMR (400 MHz, CDCl3) δ 7.33–7.28 (m, 2H), 7.24–7.20 (m, 3H), 4.31–4.22 (m, 1H), 3.04–2.84 (m, 2H), 2.75 (m, 2H), 2.19–2.08 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 140.1, 128.8, 128.7, 126.6, 42.0 (d, J = 2.0 Hz), 41.9 (d, J = 21.1 Hz), 35.9, 20.3. 19F NMR (470 MHz, CDCl3) δ −80.77 (t, J = 9.9 Hz, 3F), −110.92 to −114.85 (m, 2F), −121.55 (virt. s, 2F), −121.90 (virt. s, 4F), −122.71 (virt. s, 2F), −123.58 (virt. s, 2F), −126.07 to −126.16 (virt. m, 2F).
:
1 v/v) as the eluent system. 1H NMR (400 MHz, CDCl3) δ 7.34–7.28 (m, 2H), 7.24–7.20 (m, 3H), 4.32–4.21 (m, 1H), 3.04–2.84 (m, 2H), 2.82–2.69 (m, 2H), 2.21–2.05 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 140.1, 128.8, 128.7, 126.6, 42.0 (d, J = 2.1 Hz), 41.8 (d, J = 20.4 Hz), 35.9, 20.2. 19F NMR (470 MHz, CDCl3) δ −80.16 to −81.82 (m, 3F), −110.43 to −116.34 (m, 2F), −123.72 to −125.38 (m, 2F), −125.38 to −126.67 (m, 2F).
:
1 v/v) as the eluent system. 1H NMR (500 MHz, CDCl3) δ 7.31 (t, J = 7.9 Hz, 2H), 7.01 (t, J = 7.3 Hz, 1H), 6.92 (d, J = 7.9 Hz, 2H), 4.56–4.48 (m, 1H), 4.30 (dd, J = 10.3, 4.8 Hz, 1H), 4.18 (dd, J = 10.2, 6.9 Hz, 1H), 3.19 (ddd, J = 25.6, 16.2, 8.6 Hz, 1H), 2.80 (ddd, J = 33.5, 16.6, 8.7 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 157.9, 129.9, 122.1, 115.2, 73.0, 38.0 (t, J = 21.2 Hz), 13.0. 19F NMR (470 MHz, CDCl3) δ −80.79 (t, J = 9.9 Hz, 3F), −112.70 to −114.34 (m, 2F), −121.53 (virt. s, 2F), −121.88 (virt. s, 4F), −122.70 (virt. s, 2F), −123.51 (virt. s, 2F), −126.04 to −126.20 (m, 2F). HRMS (EI) for C17H10F17IO [M]+: calculated: 679.9505; found: 679.9504.
:
50) was synthesized according to the GP and isolated by column chromatography as sticky oil (116.0 mg, 84% yield) using petroleum ether/ethyl acetate (100
:
1 v/v) as the eluent system. 1H NMR (400 MHz, CDCl3) δ 5.71 (virt. s, 1H; 4h), 5.67 (virt. s, 1H; 4h′), 4.76–4.73 (m, 1H; 4h), 4.72 (virt. s, 1H; 4h), 2.82 (s, 2H), 2.79–2.65 (m, 4H), 2.34 (t, J = 6.2 Hz, 2H), 2.25–2.12 (m, 6H), 2.04–1.98 (m, 1H), 1.87–1.78 (m, 1H), 1.74 (s, 3H), 1.70 (s, 3H), 1.66 (s, 3H), 1.55–1.47 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 149.6, 130.03, 129.98, 127.1, 126.7, 126.3, 122.9, 109.0, 40.6, 39.0 (t, J = 21.9 Hz), 31.2, 30.9, 30.1, 30.0, 29.9, 27.9, 26.7, 21.0, 20.4, 20.0. 19F NMR (377 MHz, CDCl3) δ −80.96 (t, J = 10.0 Hz, 6F; overlapped), −111.27 to −113.80 (m, 4F; overlapped), −121.72 to −121.74 (m, 4F; overlapped), −122.02 (virt. s, 8F; overlapped), −122.83 (virt. s, 4F; overlapped), −123.30 (virt. s, 4F; overlapped), −126.24 (td, J = 14.1, 3.3 Hz, 4F; overlapped). HRMS (EI) for C18H15F17 [M]+: calculated: 554.0902; found: 554.0896.
:
14) was synthesized according to the GP and isolated by column chromatography as sticky oil (169.0 mg, 86% yield) using petroleum ether/ethyl acetate (40
:
1 v/v) as the eluent system. 1H NMR (400 MHz, CDCl3) δ 4.25–4.17 (m; overlapped 4H of minor diastereomer and 4H of major diastereomer), 3.35 (dd, J = 10.2, 3.8 Hz, 1H; minor), 3.17 (dd, J = 9.8, 5.6 Hz, 1H; major), 3.14–3.10 (m, 1H; minor), 3.05 (t, J = 9.7 Hz, 1H; major), 2.76 (q, J = 11.8 Hz, 1H; minor), 2.66–2.48 (m; overlapped 4H of major and 1H of minor), 2.35–1.99 (m; overlapped 4H of major and 6H of minor), 1.30–1.23 (m; overlapped 6H of major and 6H of minor). 13C NMR (101 MHz, CDCl3) δ 172.5 (major), 172.2 (major), 171.9 (minor), 62.1 (major), 62.04 (major), 62.01 (minor), 61.97 (minor), 58.5 (major), 58.3 (minor), 46.8 (minor), 45.6 (major), 41.1 (d, J = 2.7 Hz; minor), 40.7 (minor), 40.0 (major), 38.6 (d, J = 2.3 Hz; major), 37.9 (minor), 35.6 (major), 29.9 (t, J = 21.7 Hz; major), 14.20 (overlapped major and minor), 14.18 (overlapped major and minor), 8.56 (minor), 5.73 (major). 19F NMR (470 MHz, CDCl3) δ −81.52 (t, J = 9.9 Hz, 3F), −111.25 to −116.20 (m, 2F), −122.48 to −122.66 (m, partially overlapped 6F), −123.46 (virt. s, 2F), −124.34 (virt. s, 2F), −126.57 to −127.29 (m, 2F).
:
1 v/v) as the eluent system. 1H NMR (500 MHz, CDCl3) δ 4.13–3.99 (m, 1H), 3.68 (t, J = 5.8 Hz, 2H), 2.68–2.56 (m, 2H), 2.23–2.16 (m, 1H), 2.12–2.06 (m, 1H), 1.96–1.85 (m, 2H), 1.72–1.52 (m, 5H). 13C NMR (126 MHz, CDCl3) δ 118.9, 62.73, 54.9, 38.8, 34.8, 32.1, 24.1, 16.3.
:
1 v/v) as the eluent system. ((E)-isomer, 64.3 mg, 42%) 1H NMR (500 MHz, CDCl3) δ 6.49 (t, J = 14.3 Hz, 1H), 3.87 (virt. s, 2H), 2.94 (t, J = 6.0 Hz, 2H), 1.49 (br. s, 1H). 13C NMR (126 MHz, CDCl3) δ 129.2 (t, J = 23.8 Hz), 117.3 (t, J = 6.2 Hz), 62.1, 43.8. 19F NMR (470 MHz, CDCl3) δ −80.77 (t, J = 9.9 Hz, 3F), −105.03 (q, J = 13.5 Hz, 2F), −121.44 (virt. s, 2F), −121.89 (virt. s, 4F), −122.72 (virt. s, 2F), −123.08 (virt. s, 2F), −126.07 to −126.18 (m, 2F). ((Z)-isomer, 52.9 mg, 34%) 1H NMR (500 MHz, CDCl3) δ 6.41 (t, J = 13.0 Hz, 1H), 3.85 (t, J = 5.8 Hz, 2H), 2.92 (t, J = 5.2 Hz, 2H), 1.55 (br. s, 1H). 13C NMR (126 MHz, CDCl3) δ 124.5 (t, J = 23.8 Hz), 111.8 (t, J = 6.6 Hz), 60.8, 51.2. 19F NMR (470 MHz, CDCl3) δ −80.82 (t, J = 9.9 Hz, 3F), −108.82 (q, J = 12.6 Hz, 2F), −121.49 (virt. s, 2F), −121.93 (virt. s, 4F), −122.77 (virt. s, 2F), −122.89 (virt. s, 2F), −126.13 to −126.19 (m, 2F).
:
1 v/v) as the eluent system. ((E)-isomer) 1H NMR (500 MHz, CDCl3) δ 7.26 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.8 Hz, 2H), 6.55 (t, J = 13.5 Hz, 1H), 3.82 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 160.4, 133.8, 129.0, 126.6 (t, J = 21.6 Hz), 113.6, 55.5. 19F NMR (470 MHz, CDCl3) δ −80.75 (t, J = 9.9 Hz, 3F), −104.84 (q, J = 13.1 Hz, 2F), −121.47 (virt. s, 2F), −121.89 (virt. s, 4F), −122.72 (virt. s, 2F), −122.83 (virt. s, 2F), −126.06 to −126.15 (m, 2F). ((Z)-isomer could not be totally separated from the (E)-isomer, and its pure NMR spectrum were not obtained.)
:
1 v/v) as the eluent system. 1H NMR (400 MHz, CDCl3) δ 7.45–7.40 (m, 2H), 7.35–7.24 (m, 3H), 5.44 (dd, J = 9.7, 5.2 Hz, 1H), 3.39–3.08 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 143.0, 129.1, 128.8, 127.0, 42.8 (t, J = 20.6 Hz), 16.7. 19F NMR (470 MHz, CDCl3) δ −80.68 to −81.19 (m, 3F), −111.85 to −115.16 (m, 2F), −121.83 (virt. s, 2F), −122.75 to −123.13 (m, 2F), −123.58 (virt. s, 2F), −126.04 to −126.44 (m, 2F). HRMS (EI) for C14H8F13 [M
−
I]+: calculated: 423.0413; found: 423.0423.
:
1 v/v) as the eluent system. 1H NMR (400 MHz, CDCl3) δ 7.33 (d, J = 8.2 Hz, 1H), 7.27 (d, J = 7.8 Hz, 1H), 7.22 (s, 1H), 7.12 (td, J = 16.1 and 2.0 Hz, 1H), 6.16 (dd, J = 28.2, 12.3 Hz, 1H), 2.97–2.91 (m, 2H), 2.57–2.40 (m, 2H), 2.37–2.27 (m, 1H), 2.22–1.95 (m, 4H), 1.71–1.42 (m, 6H), 0.92 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 220.8, 142.6, 139.7 (t, J = 9.6 Hz), 137.5, 131.4, 128.5, 126.2, 125.2, 113.8 (t, J = 23.0 Hz), 50.8, 48.2, 44.8, 38.2, 36.0, 31.8, 29.5, 26.5, 25.9, 21.8, 14.0. 19F NMR (377 MHz, CDCl3) δ −80.78 (t, J = 9.9 Hz, 3F), −110.88 (q, J = 12.3 Hz, 2F), −121.33 (virt. s, 2F), −121.90 (virt. s, 4F), −122.70 (virt. s, 2F), −123.11 to −123.32 (m, 2F), −125.99 to −126.29 (m, 2F). HRMS (ESI) for C28H23F17O [M]+: calculated: 698.1477; found: 698.1470.
Footnote |
| † Electronic supplementary information (ESI) available. See DOI: 10.1039/c8ra06181e |
| This journal is © The Royal Society of Chemistry 2018 |